• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . Whole-genome sequencing to track SARS-CoV-2 transmission in nosocomial outbreaks

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2020 Sep 19;ciaa1433.
doi: 10.1093/cid/ciaa1433. Online ahead of print.
Whole-genome sequencing to track SARS-CoV-2 transmission in nosocomial outbreaks


Mary Lucey[SUP] 1 [/SUP], Guerrino Macori[SUP] 2 [/SUP], Niamh Mullane[SUP] 1 [/SUP], Una Sutton-Fitzpatrick[SUP] 1 [/SUP], Gabriel Gonzalez[SUP] 3 [/SUP], Suzie Coughlan[SUP] 3 [/SUP], Aisling Purcell[SUP] 4 [/SUP], Lynda Fenelon[SUP] 1 [/SUP], S?amus Fanning[SUP] 2 [/SUP], Kirsten Schaffer[SUP] 1 [/SUP]



Affiliations

Abstract

Background: During the first wave of the coronavirus disease 2019 (COVID-19) pandemic, outbreaks of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in healthcare institutions posed a significant problem. Due to limited evidence, guidance on appropriate infection prevention and control (IPC) measures such as the wearing of face masks varied. Here, we applied whole virus genome sequencing (WvGS) to analyse transmission routes of SARS-CoV-2 in hospital-acquired (HA) COVID-19.
Methods: An investigation was undertaken for all HA cases of COVID-19 from March to April 2020. Fifty SARS-CoV-2 samples were analysed by WvGS and their phylogenetic relationship established.
Results: WvGS identified transmission events previously undetected by epidemiological analysis and provided evidence for SARS-CoV-2 transmission between healthcare workers (HCW) and patients and among HCW themselves. The majority of HA COVID-19 cases occurred in patients highly dependent on nursing care, suggesting the likely route of transmission was by close contact or droplet, rather than aerosol, transmission. Mortality among HA COVID-19 infections was recorded as 33%.
Conclusions: This study provides evidence that SARS-CoV-2 transmission occurs from symptomatic and asymptomatic HCWs to patients. Interventions including comprehensive screening of HCWs for COVID-19 symptoms, PCR testing of asymptomatic HCWs upon identification of HA cases and implementation of universal use of surgical masks for all clinical care is indicated to prevent viral transmission. Our study highlights the importance of close collaboration between guidance bodies and frontline IPC experts for developing control measures in an emergency pandemic situation caused by a virus with undefined transmission modus.

Keywords: Whole virus genome sequencing; infection prevention and control; nosocomial outbreaks; severe acute respiratory syndrome coronavirus 2.
 
Back
Top Bottom